Dorottya Vaskó

Dorottya Vaskó

Auto-generated profile, based on publicly available information

Dorottya Vaskó

Department of Organic Chemistry and Technology, Faculty of Chemical Technology and Biotechnology, Budapest University of Technology and Economics, Műegyetem rkp. 3., H-1111 Budapest, Hungary

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
DVDorottya Vaskó
Dorottya Vaskó
DHDorottya Katalin Hajdú
Dorottya Katalin Hajdú
EMEszter Márkus
Eszter Márkus
EPEszter Pantea
Eszter Pantea
DUDóra Ujj
Dóra Ujj
EHEdit Hirsch
Edit Hirsch

12 July 2023 in Food Technology and Biotechnology
Verified
Journal Article
Closed access
DVDorottya Vaskó
Dorottya Vaskó
JDJulia Domjan
Julia Domjan
BSBence Szűcs
Bence Szűcs
LBLászló Bakk
László Bakk
Péter HajdinákPéter Hajdinák
Péter Hajdinák
CFCsaba Fehér
Csaba Fehér
Research background. Protein A affinity chromatography is a well-established method currently used in the pharmaceutical industry. However, the high costs usually associated with chromatographic separation of protein A and the difficulties in continuous operation make the investigation of alternative purification methods very important. Experimental approach. In this study, extraction/back-extraction and precipitation/dissolution methods were developed and optimised. They were compared with protein A and cation exchange chromatography separations in terms of yield of monoclonal antibody (mAb) and amount of residual impurities, such as DNA and host cell proteins, and amount of mAb aggregates. For a comprehensive comparison of the different methods, experiments were carried out with the same cell-free fermentation broth containing adalimumab. Results and conclusions. Protein A and cation exchange chromatographic separations resulted in high yield and purity of adalimumab. The precipitation-based process resulted in high yield but with lower purity. The extraction-based purification resulted in low yield and purity. Thus, the precipitation-based method proved to be more promising than the extraction-based method for direct purification of adalimumab from harvested cell culture fluid. Novelty and scientific contribution. Although alternative purification methods may offer the advantages of simplicity and low-cost operation, further significant improvements are required to compete with the performance of chromatographic separations of adalimumab from true fermentation broth.